167 related articles for article (PubMed ID: 23038789)
1. Time from emerging heart failure symptoms to cardiac resynchronisation therapy: impact on clinical response.
Verbrugge FH; Dupont M; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
Heart; 2013 Mar; 99(5):314-9. PubMed ID: 23038789
[TBL] [Abstract][Full Text] [Related]
2. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
3. Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians.
Verbrugge FH; Dupont M; De Vusser P; Rivero-Ayerza M; Van Herendael H; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
Eur J Heart Fail; 2013 Feb; 15(2):203-10. PubMed ID: 23002114
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.
Verbrugge FH; Dupont M; Rivero-Ayerza M; de Vusser P; Van Herendael H; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
J Card Fail; 2012 Nov; 18(11):845-53. PubMed ID: 23141857
[TBL] [Abstract][Full Text] [Related]
6. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
9. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
10. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
[TBL] [Abstract][Full Text] [Related]
11. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular function and survival following cardiac resynchronisation therapy.
Leong DP; Höke U; Delgado V; Auger D; Witkowski T; Thijssen J; van Erven L; Bax JJ; Schalij MJ; Marsan NA
Heart; 2013 May; 99(10):722-8. PubMed ID: 23315608
[TBL] [Abstract][Full Text] [Related]
13. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure.
Versteeg H; van den Broek KC; Theuns DA; Mommersteeg PM; Alings M; van der Voort PH; Jordaens L; Pedersen SS
Am J Cardiol; 2011 Oct; 108(8):1155-9. PubMed ID: 21821227
[TBL] [Abstract][Full Text] [Related]
14. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
Wang CL; Powell BD; Redfield MM; Miyazaki C; Fine NM; Olson LJ; Cha YM; Espinosa RE; Hayes DL; Hodge DO; Lin G; Friedman PA; Oh JK
Eur J Heart Fail; 2012 May; 14(5):517-25. PubMed ID: 22411692
[TBL] [Abstract][Full Text] [Related]
16. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
[TBL] [Abstract][Full Text] [Related]
17. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
[TBL] [Abstract][Full Text] [Related]
18. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
[TBL] [Abstract][Full Text] [Related]
19. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
